Julian Matthewman Selected Research

Stroke (Strokes)

7/2022

Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julian Matthewman Research Topics

Disease

3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023 - 01/2023
3	Asthma (Bronchial Asthma) 01/2023 - 12/2022
3	Eczema 01/2023 - 12/2022
2	Osteoporotic Fractures 01/2023 - 01/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2023
1	Skin Diseases (Skin Disease) 01/2023
1	Psoriatic Arthritis 01/2023
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2023
1	Melanoma (Melanoma, Malignant) 07/2022
1	Necrosis 07/2022
1	Neoplasms (Cancer) 07/2022
1	COVID-19 07/2022
1	Stroke (Strokes) 07/2022
1	Skin Neoplasms (Skin Cancer) 07/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2022
1	Atopic Dermatitis (Atopic Eczema) 01/2022
1	Scabies (Sarcoptic Mange) 01/2020
1	Infections 11/2019

Drug/Important Bio-Agent (IBA)

3	GlucocorticoidsIBA 01/2023 - 07/2022
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 01/2022
1	A 17 (A-17)IBA 01/2023
1	Prednisolone (Predate)FDA LinkGeneric 01/2023
1	GoldIBA 12/2022
1	Interleukin-6 InhibitorsIBA 07/2022
1	InterleukinsIBA 07/2022
1	Interleukin-12 (IL 12)IBA 07/2022
1	Janus Kinase InhibitorsIBA 07/2022
1	Rituximab (Mabthera)FDA Link 07/2022
1	benzyl benzoate (Ansar)FDA Link 01/2020
1	Indicators and Reagents (Reagents)IBA 11/2019

Therapy/Procedure

2	Therapeutics 01/2023 - 07/2022